BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18549684)

  • 21. Clinical and metabolic characteristics of Turkish adolescents with polycystic ovary syndrome.
    Ates S; Aydın S; Ozcan P; Soyman Z; Gokmen Karasu AF; Sevket O
    J Obstet Gynaecol; 2018 Feb; 38(2):236-240. PubMed ID: 28920502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Revised criteria for PCOS in WHO Group II anovulatory infertility - a revival of hypothalamic amenorrhoea?
    Lauritsen MP; Pinborg A; Loft A; Petersen JH; Mikkelsen AL; Bjerge MR; Nyboe Andersen A
    Clin Endocrinol (Oxf); 2015 Apr; 82(4):584-91. PubMed ID: 25262871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H; Tanir HM; Yildiz Z
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The value of the GnRH double stimulation test in differentiation of oligo-amenorrhea].
    Rossmanith WG; Schramm S; Benz R; Lauritzen C
    Gynakol Rundsch; 1991; 31 Suppl 2():331-3. PubMed ID: 1790970
    [No Abstract]   [Full Text] [Related]  

  • 25. Updated ultrasound criteria for polycystic ovary syndrome: reliable thresholds for elevated follicle population and ovarian volume.
    Lujan ME; Jarrett BY; Brooks ED; Reines JK; Peppin AK; Muhn N; Haider E; Pierson RA; Chizen DR
    Hum Reprod; 2013 May; 28(5):1361-8. PubMed ID: 23503943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Classification of normogonadotropic infertility: polycystic ovaries diagnosed by ultrasound versus endocrine characteristics of polycystic ovary syndrome.
    van Santbrink EJ; Hop WC; Fauser BC
    Fertil Steril; 1997 Mar; 67(3):452-8. PubMed ID: 9091329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Herbal medicine for the management of polycystic ovary syndrome (PCOS) and associated oligo/amenorrhoea and hyperandrogenism; a review of the laboratory evidence for effects with corroborative clinical findings.
    Arentz S; Abbott JA; Smith CA; Bensoussan A
    BMC Complement Altern Med; 2014 Dec; 14():511. PubMed ID: 25524718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gonadotrophin control of follicular development.
    Abdulwahid NA; Adams J; van der Spuy ZM; Jacobs HS
    Clin Endocrinol (Oxf); 1985 Dec; 23(6):613-26. PubMed ID: 3938350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive value of menstrual cycle pattern, body mass index, hormone levels and polycystic ovaries at age 15 years for oligo-amenorrhoea at age 18 years.
    van Hooff MH; Voorhorst FJ; Kaptein MB; Hirasing RA; Koppenaal C; Schoemaker J
    Hum Reprod; 2004 Feb; 19(2):383-92. PubMed ID: 14747186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accuracy of anti-Müllerian hormone and total follicles count to diagnose polycystic ovary syndrome in reproductive women.
    Wongwananuruk T; Panichyawat N; Indhavivadhana S; Rattanachaiyanont M; Angsuwathana S; Techatraisak K; Pratumvinit B; Sa-Nga-Areekul N
    Taiwan J Obstet Gynecol; 2018 Aug; 57(4):499-506. PubMed ID: 30122568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age-related differences in features associated with polycystic ovary syndrome in normogonadotrophic oligo-amenorrhoeic infertile women of reproductive years.
    Bili H; Laven J; Imani B; Eijkemans MJ; Fauser BC
    Eur J Endocrinol; 2001 Dec; 145(6):749-55. PubMed ID: 11720900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of progesterone deficiency in the development of luteinizing hormone and androgen abnormalities in polycystic ovary syndrome.
    Fiad TM; Cunningham SK; McKenna TJ
    Eur J Endocrinol; 1996 Sep; 135(3):335-9. PubMed ID: 8890725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Augmented frequency and mass of LH discharged per burst are accompanied by marked disorderliness of LH secretion in adolescents with polycystic ovary syndrome.
    García-Rudaz MC; Ropelato MG; Escobar ME; Veldhuis JD; Barontini M
    Eur J Endocrinol; 1998 Dec; 139(6):621-30. PubMed ID: 9916868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the phenotype of Chinese versus Dutch Caucasian women presenting with polycystic ovary syndrome and oligo/amenorrhoea.
    Guo M; Chen ZJ; Eijkemans MJ; Goverde AJ; Fauser BC; Macklon NS
    Hum Reprod; 2012 May; 27(5):1481-8. PubMed ID: 22402209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].
    Parahuleva N; Pehlivanov B; Orbecova M; Uchikova E; Ivancheva H
    Akush Ginekol (Sofiia); 2014; 53(5):22-7. PubMed ID: 25558667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
    Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new ultrasound criterion for the diagnosis of polycystic ovary syndrome: the ovarian stroma/total area ratio.
    Fulghesu AM; Ciampelli M; Belosi C; Apa R; Pavone V; Lanzone A
    Fertil Steril; 2001 Aug; 76(2):326-31. PubMed ID: 11476780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles.
    Dewailly D; Alebić MŠ; Duhamel A; Stojanović N
    Hum Reprod; 2014 Nov; 29(11):2536-43. PubMed ID: 25267785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome.
    Taylor AE; McCourt B; Martin KA; Anderson EJ; Adams JM; Schoenfeld D; Hall JE
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2248-56. PubMed ID: 9215302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.